1. 1) Takeda H., Takeda T., Kobayashi S., Takeda T. : Hyperthermic immunotherapy was effective in 3 CR cases as the standard treatments had no effect or could not be enforced. Gan To Kagaku Ryoho (Jpn J Cancer Chemotherapy), 38 : 1939-1941, 2011. (Japanease).
2. 2) Takeda T., Xianhui D., Takeda H., Haba A., Takeda Y. : Successful immunotherapy combined with hyperthermia for cancer patients. Gan To Kagaku Ryoho (Jpn J Cancer Chemotherapy), 33 : 1739-1741, 2006. (Japanease).
3. 3) Takeda T., Fukunaga K., Miyazawa K., Takahashi T., Takeda H., Takeda Y., Tanigawa K., Morisaki T., Yamamoto I., Hasegawa T. : Hyperthermic immuno-cellular therapy- Basic and clinical studies. Gan To Kagaku Ryoho (Jpn J Cancer Chemotherapy), 35 : 2244-2246, 2008. (Japanease).
4. 4) Takeda T., Hasegawa T., Miyazawa K., Yoshida K., Takeda T., Takeda H., Takahashi T., Yamamoto I., Kobayashi S. : Hyperthermia enhances activated lymphocytes and molecular target therapy. Gan To Kagaku Ryoho (Jpn J Cancer Chemotherapy), 38 : 1924-1926, 2011. (Japanease).
5. 5) Takeda T., Miyazawa K., Takeda T., Takeda H., Takeda Y. : Multidisciplinary therapy for 984 cancer patients - Hyperthermic immunotherapy. Gan To Kagaku Ryoho (Jpn J Cancer Chemotherapy), 37 : 2243-2245, 2010. (Japanease).